rxstatShortages › Tirzepatide

Tirzepatide (Mounjaro) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Tirzepatide is in a widespread shortage in Canada. 6 of 6 reported products are affected. Manufacturers have not committed to a recovery date.

A diabetes and weight management medication used to control blood sugar in type 2 diabetes and support weight loss.

Products affected
6 / 6
In shortage since
Jan 22, 2025
Reports on file
12
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
MOUNJARO
15MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541106 · since Jan 22, 2025, no end estimate
Active shortage
MOUNJARO
12.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541092 · since Apr 3, 2025, no end estimate
Active shortage
MOUNJARO
10MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541084 · since Mar 17, 2025, no end estimate
Active shortage
MOUNJARO
7.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541076 · since Mar 5, 2025, no end estimate
Active shortage
MOUNJARO
5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541068 · since Oct 1, 2025, no end estimate
Active shortage
MOUNJARO
2.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541041 · since Oct 1, 2025, no end estimate
Resolved
MOUNJARO
15MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541106 · ended Dec 2, 2024 · For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Resolved
MOUNJARO
12.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541092 · ended Dec 2, 2024 · For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Resolved
MOUNJARO
7.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541076 · ended Aug 30, 2024
Resolved
MOUNJARO
10MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541084 · ended Aug 30, 2024
Resolved
MOUNJARO
2.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541041 · ended Jun 17, 2024
Resolved
MOUNJARO
5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541068 · ended Jun 17, 2024

What's happening

Tirzepatide is currently affected by 6 active shortage reports filed with Health Canada by ELI LILLY CANADA INC.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

What is Tirzepatide used for?

A diabetes and weight management medication used to control blood sugar in type 2 diabetes and support weight loss.

When will Tirzepatide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Tirzepatide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.